Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (8718)	2/11/2002 1:10:12 AM
From: russet	Read Replies (2) \| Respond to of 14101

Latest news Study of cancer sufferers will evaluate cannabis pain relief source: Nature \| home \| current issue \| subscribe \| British research into the clinical use of cannabis is to be extended to include studies of pain relief in cancer sufferers. More than 100 people with terminal cancer will take part in the trials, in which whole-plant extracts of cannabis will be given as a spray under the tongue. The company behind the study, Salisbury-based GW Pharmaceuticals, is already testing cannabis on patients with multiple sclerosis and spinal-cord injuries. The attitude of British officials towards medical cannabis use has softened in recent months. Home Secretary David Blunkett said in October that the law could be changed to allow clinical use if trials were successful. --------------------------------------------------------------------------------